The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor

NCT03085485 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease
Chronic Bronchitis

Interventions

DRUG: Ivacaftor 150 MG
DRUG: Placebo

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]
[object Object]